US equities |
MU $904.90 ▲+0.00% SNDK $1,371.12 ▲+0.00% NVDA $217.09 ▲+0.00% SPCX $147.96 ▲+0.00% AAPL $342.94 ▲+0.00% SKHY $142.87 ▲+0.00% TSLA $368.06 ▲+0.00% INTC $92.03 ▲+0.00%
FinancialContent

Latest News about KGK Science

Recent news which mentions KGK Science

KGK Sciences And Halucenex Sign Contract For Phase II Clinical Trial On Psilocybin For PTSD
Tickers COPHF KONEF
Tags Benzinga Halucenex Life Sciences Bill Flemming
From Benzinga
Wellbeing Digital Introduces Women In Psychedelics, A Network For Female Minds In Psychedelics
Tickers KONEF
Tags News Guidance Market News
From Benzinga